1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Kenny-Caffey syndrome, Type 1: new trials by email Literature Review of Kenny-Caffey syndrome, Type 1 trials Research Report on Kenny-Caffey syndrome, Type 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors SYN818 and Olaparib will be administered - Metastatic Solid Tumor, Ovarian Cancer | Phase 1 | Recruiting | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 110 | 2025-08-26 | 2025-09-05 |
Breast Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1)
Adnexal Diseases (1) · Breast Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Ovarian Diseases (1) · Pathologic Processes (1)
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd (1)
China (1)